1-6 of 6
Jason R. Gotlib, MDMS
Close
Sort by
Journal Articles

Solid Tumors in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: A Study on 2220 Patients

Barbara Mora, Elisa Rumi, MD, Paola Guglielmelli, MD PhD, Daniela Barraco, MD, Margherita Maffioli, MD, Alessandro Rambaldi, MD, Marianna Caramella, MD, Rami S. Komrokji, MD, Jason R. Gotlib, MDMS, Jean-Jacques Kiladjian, MD PhD, Francisco Cervantes, MD PhD, Timothy Devos, Francesca Palandri, PhD MD, Valerio De Stefano, MD, Marco Ruggeri, MD, Richard T. Silver, MD, Giulia Benevolo, MD, Francesco Albano, MD, Chiara Cavalloni, MD, Daniela Pietra, PhD, Tiziano Barbui, MD, Giada Rotunno, PhD, Mario Cazzola, Alessandro M. Vannucchi, MD, Toni Giorgino, PhD, Francesco Passamonti, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3039.
https://doi.org/10.1182/blood-2018-99-115318
Published: 2018
Journal Articles

Interim Results from Fight-203, a Phase 2, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Pemigatinib (INCB054828) in Patients with Myeloid/Lymphoid Neoplasms with Rearrangement of Fibroblast Growth Factor Receptor 1 ( FGFR1 )

Srdan Verstovsek, MD PhD, Alessandro M. Vannucchi, MD, Alessandro Rambaldi, MD PhD, Jason R. Gotlib, MDMS, Adam J. Mead, MD PhD, Andreas Hochhaus, MD, Jean-Jacques Kiladjian, MD PhD, Juan Carlos Hernandez Boluda, MD PhD, Ekaterine Asatiani, MD, Christine Lihou, BS, Huiling Zhen, MD PhD, Andreas Reiter, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 690.
https://doi.org/10.1182/blood-2018-99-110388
Published: 2018
Journal Articles

Avapritinib, a Potent and Selective Inhibitor of KIT D816V, Improves Symptoms of Advanced Systemic Mastocytosis (AdvSM): Analyses of Patient Reported Outcomes (PROs) from the Phase 1 (EXPLORER) Study Using the (AdvSM) Symptom Assessment Form (AdvSM-SAF), a New PRO Questionnaire for (AdvSM)

Jason R. Gotlib, MDMS, Deepti Radia, MD, Daniel J. DeAngelo, MD, Prithviraj Bose, MD, Mark W Drummond, PhDMD, Elizabeth O. Hexner, MDMS, William A Robinson, MD PhD, Maureen G. Conlan, MD, Ronny G. Oren, MS, Hongliang Shi, Michael W. Deininger, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 351.
https://doi.org/10.1182/blood-2018-99-112017
Published: 2018
Journal Articles

PRM-151 in Myelofibrosis: Efficacy and Safety in an Open Label Extension Study

Srdan Verstovsek, MD PhD, Robert P. Hasserjian, MD, Olga Pozdnyakova, MD PhD, Ivo Veletic, MD, Ruben A. Mesa, MD, Lynda Foltz, MD FRCPC, John Mascarenhas, MD, Ellen K. Ritchie, MD, Jeanne Palmer, MD, Richard T. Silver, MD, Marina Kremyanskaya, MD PhD, Bernt van den Blink, MD PhD, Renu Gupta, MD, Taghi Manshouri, PhD, C. Cameron Yin, MD PhD, Zeev E. Estrov, MD, Jason R. Gotlib, MDMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 686.
https://doi.org/10.1182/blood-2018-99-115362
Published: 2018
Journal Articles

Phase 2 Study of Ruxolitinib in Patients with Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

Kim-Hien Dao, DO,PhD, Robert H. Collins, MD, Jorge E. Cortes, MD, Michael W. Deininger, MD PhD, Brian J. Druker, MD, Jason R. Gotlib, MDMS, Tara Alyson Macey, PhD, Stephen T Oh, MD PhD, Jeffrey W. Tyner, PhD, Elliott F. Winton, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 350.
https://doi.org/10.1182/blood-2018-99-119476
Published: 2018
Journal Articles

Comprehensive Cytokine Profiling of Patients with Advanced Systemic Mastocytosis Treated with Midostaurin

Asiri Ediriwickrema, MD, Daniel J. DeAngelo, MD, Tracy I. George, MD, Yael Rosenberg-Hasson, Cecelia Perkins, Cheryl Langford, Jason R. Gotlib, MDMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1792.
https://doi.org/10.1182/blood-2018-99-117689
Published: 2018